Fig. 2: Scatterplots of pairs of D35 antibody marker values (spike IgG, RBD IgG, pseudovirus nAb-ID50) for baseline SARS-CoV-2 negative per-protocol vaccine recipients in the immunogenicity subcohort (U.S. study sites). | Nature Communications

Fig. 2: Scatterplots of pairs of D35 antibody marker values (spike IgG, RBD IgG, pseudovirus nAb-ID50) for baseline SARS-CoV-2 negative per-protocol vaccine recipients in the immunogenicity subcohort (U.S. study sites).

From: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Fig. 2

Source data are provided in Fig. 2 Source Data file. Corr, Spearman rank correlation; D35, Day 35 visit; nAb-ID50, 50% inhibitory dilution neutralizing antibody titer; RBD receptor binding domain.

Back to article page